The direction of the market and unsettled economic circumstances are changing the dynamics of success in digital health.
On the back of a pandemic-fuelled innovation and fundraising boom, the future outlook is more combative and complex – defined by competition for capital, regulatory scrutiny and fast cross-border expansion. Raising capital on sustainable terms, bringing effective products to market quickly and protecting competitive position are all increasingly critical to success, and increasingly challenging to achieve.
Digital health leaders need a new growth playbook that is built for this moment.
Breakthrough Digital Health combines research with a collection of ideas and experiences from digital health leaders and the Taylor Wessing experts who partner them, exploring how to grow through make or break moments.
your experiences, challenges and opportunities against 250 other digital health businesses.
insight from a community of innovators, investors and legal experts – covering capital raising, international expansion, the regulatory environment and more.
the key principles of success in an increasingly complex and competitive digital health industry.
Here's a snapshot of what the 250 digital health leaders we spoke to told us:
How we can help you break through
In dynamic digital health, success depends on the ability to bring new solutions to market, realise revenue and scale quickly. Progress is often disrupted where fast-paced innovation collides with the law, but opportunities abound for digital health innovators that can break through.
Taylor Wessing helps digital health companies grow through make or break moments. We spot legal issues early that could compromise vision or value, support clients to weigh commercial decisions against regulatory limitations and propose simple solutions that overcome inherent industry complexity.
If you’re preparing for your next funding round, this section is for you. Read about the current fundraising environment, what’s worrying fellow innovators and how to access finance on favourable terms.
Read this if you’re concerned about the impact of regulation on growth. Discover how other innovators feel about regulatory obstacles and how to align your commercial and regulatory strategies.
If you’re on a mission to scale up, visit this section to compare other innovators’ plans and consider how to overcome the obstacles associated with expanding into new markets, building product functionality and value growth.
Dr. Manja Epping
Thanos Rammos, LL.M.
Dr. Daniel Tietjen
Karolina Lange-Kulmann, LL.M. (Medizinrecht)
AI software ChatGPT – actually a medical device?
Karlsruhe Higher Regional Court considers the granting of valuable bonus points for the pre-ordering of prescription medicines using smartphone app
Trade mark protection for medical devices and digital health products
EU Health Technology Assessment (HTA) Regulation (2021/2282) of January 11, 2022.
Background: History of the HTA Regulation
A new set of challenges for start-ups to conquer the next digital health frontier
New survey finds three-quarters of digital health leaders believe industry is at saturation point for wellness solutions and a new revolution is necessary